Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2901 of 5804
-
New hope for Hard-to-Treat blood cancers? early trial targets genetic weakness
Disease control OngoingThis research study is testing if Talazoparib is an effective treatment for patients with AML and MDS that have a mutation in the cohesin complex.
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New app aims to ease cancer pain for kids at home
Symptom relief CompletedThe purpose of this study is to examine the feasibility of the ambulatory monitoring protocol, called Pain Buddy, in documenting children's pain, symptoms and quality of life while receiving outpatient chemotherapy. The long term goal of Pain Buddy is to help doctors, nurses, and…
Phase: NA • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Could a magnetic helmet calm Seizure-Like brain waves in sleeping children?
Symptom relief CompletedThe investigators are investigating the effectiveness of a wearable multisite transcranial magnetic stimulation (mTMS) device that can deliver stimuli at multiple cortical sites simultaneously or sequentially for the treatment of an epileptic syndrome - focal continuous-spike and…
Phase: NA • Sponsor: Children's Mercy Hospital Kansas City • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Vein-Blocking device shows promise for heart failure patients
Symptom relief CompletedSafety and performance evaluation of the preCARDIA System for patients with ADHF.
Phase: NA • Sponsor: Abiomed Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Brain training for daily life: new approach may help seniors with memory loss
Symptom relief CompletedLoss of cognitive abilities leading to Alzheimer's disease is progressive and destructive, leaving older adults disabled and unable to recall their past. The number of older adults with Alzheimer's disease is expected to triple by the year 2050, yet little research examines amylo…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Smart pill bottles and video visits boost cancer drug adherence
Symptom relief CompletedThis phase II trial studies how well telehealth works in improving adherence to endocrine (anti-estrogen) therapy in participants with estrogen receptor and/or progesterone receptor positive (hormone receptor positive) stage 0-III breast cancer who have underwent surgery. Telehea…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Personalized craving scale shows promise for addiction treatment
Symptom relief CompletedThe management of the craving is a key element in addiction treatment as the craving is linked to the probability of relapse. Several cues could induce the craving, some generic substance-induced cues or addictive behavior-related cues (e.g. gambling-related cues), and also some …
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New inhaled drug shows promise for easing lung pressure in rare Heart-Lung condition
Symptom relief CompletedThis multicenter, open label, Phase 2a study is designed to evaluate the effect of inhaled RT234 delivered in a dose escalation manner on the change in pulmonary vascular resistance (PVR) in subjects with Pulmonary Arterial Hypertension (PAH) undergoing Right heart catheterizatio…
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New pill aims to keep leukemia at bay after transplant
Disease control CompletedThis is a single-center Phase 1 trial of 20 patients with AML/MDS. Eligible patients will be enrolled following an informed consent between 6-20 weeks after allogeneic hematopoietic stem cell transplant. Patients will receive weekly oral ONC 201 for a total of 52 weeks.
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Talking therapy may ease veterans' post-surgery pain
Symptom relief CompletedPrimary Aim: To examine the superior efficacy of ACT versus Attention Control (AC) on postoperative pain intensity and functioning in at-risk Veterans undergoing TKA. Changes in pain intensity and functioning from baseline to 6 weeks, 3 months and 6 months post-TKA will be compar…
Phase: NA • Sponsor: University of Iowa • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Brain scans reveal how mindfulness rewires PTSD Patients' minds
Knowledge-focused CompletedThis study will examine the effects of psychotherapy as treatment for PTSD, and specifically how brain activity and brain connectivity is affected by Mindfulness Based Cognitive Therapy (MBCT) and an active mind-body comparison comparison therapy.
Phase: NA • Sponsor: Ohio State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Headband may ease withdrawal after cushing surgery
Symptom relief Recruiting nowCushing syndrome (CS) is an endocrine disorder caused by chronic exposure to glucocorticoid (GC) excess. Endogenous CS has an estimated incidence of 0.2 to 5.0 cases per million per year and prevalence of 39 to 79 cases per million in various populations. CS usually affects young…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 26, 2026 12:36 UTC
-
Video games that read muscles show promise for kids with cerebral palsy
Symptom relief CompletedCerebral palsy (CP) is a major motor dysfunction manifesting early in childhood, with severe consequences to performance in daily functions. CP children are typically unable to voluntarily activate individual muscles, hindering motor coordination and therefore the ability to prod…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Fatty liver drug showdown: ornithine aspartate vs silymarin
Disease control CompletedThis is a multicenter, randomized, double-blind, double-dummy, and positive control clinic trial which explores the efficacy and safety of ornithine aspartate granules in the treatment of non-alcoholic fatty liver disease against silymarin capsules. The hypothesis is that the orn…
Phase: PHASE4 • Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Immunotherapy combo before liver surgery shows promise for advanced colorectal cancer
Disease control TerminatedThis phase II trials studies how well pembrolizumab and vactosertib work after standard of care chemotherapy in patients with colorectal cancer that has spread to the liver that can be removed by surgery (resectable hepatic metastases). Immunotherapy with monoclonal antibodies, s…
Phase: PHASE2 • Sponsor: Chloe Atreya, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a daily baby aspirin help moms recover from severe preeclampsia?
Disease control Recruiting nowThe purpose of this research study is to find out whether women with severe preeclampsia taking low-dose aspirin (LDA) for 3 weeks post-delivery will experience an improvement in endothelial function (measured as flow-mediated dilation - FMD) and severity of disease, as the effec…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Which radiation is easier on prostate cancer patients? small trial aims to find out
Disease control OngoingThis phase II trial compares high-dose rate brachytherapy and stereotactic ablative radiotherapy as monotherapy in treating patients with prostate cancer that has not spread to other parts of the body (localized). High-dose rate brachytherapy delivers radiation directly into the …
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 26, 2026 18:27 UTC
-
New study aims to ease agitated delirium in dying cancer patients
Symptom relief OngoingThis phase II/IIII trial studies how well haloperidol and lorazepam work in controlling symptoms of persistent agitated delirium in patients with cancer that has spread to other places in the body undergoing palliative care. Haloperidol and lorazepam may help in controlling sympt…
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New scan could reveal cancer drug success in days, not months
Diagnosis CompletedMetastatic kidney cancer is usually treated with targeted therapy or immunotherapy which is costly and has low response rate. The current standard care is to perform anatomical imaging studies after a few cycles (months) of treatment to evaluate response. This approach exposes ma…
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Can family programs cut obesity and cancer risk? new study tests two approaches
Disease control OngoingThis clinical trial compares the effects of parent/caregiver-focused programs to family-focused programs in reducing obesity risk in racial ethnic minority families. Obesity tends to run in families, thus family-based interventions have been strongly recommended. Parent and famil…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC